This differential expression likely reflects the divergent oncogenic mechanisms underlying SRCC as compared to the gland-forming intestinal-type adenocarcinomas, suggesting that Gal-1 may play subtype-specific roles in gastric cancer pathogenesis. This evidence concerns the gene LGALS1 and gastric cancer.